Your browser doesn't support javascript.
loading
Improving treatment outcomes for MDR-TB - Novel host-directed therapies and personalised medicine of the future.
Rao, Martin; Ippolito, Giuseppe; Mfinanga, Sayoki; Ntoumi, Francine; Yeboah-Manu, Dorothy; Vilaplana, Cris; Zumla, Alimuddin; Maeurer, Markus.
Afiliação
  • Rao M; ImmunoSurgery Unit, Champalimaud Centre for the Unknown, Lisbon, Portugal. Electronic address: martin.rao@research.fchampalimaud.org.
  • Ippolito G; National Institute for Infectious Diseases, Lazzaro Spallanzani, Rome, Italy. Electronic address: giuseppe.ippolito@inmi.it.
  • Mfinanga S; National Institute of Medical Research Muhimbili, Dar es Salaam, Tanzania. Electronic address: gsmfinanga@yahoo.com.
  • Ntoumi F; University Marien NGouabi and Fondation Congolaise pour la Recherche Médicale (FCRM), Brazzaville, Congo; Institute for Tropical Medicine, University of Tübingen, Germany. Electronic address: ffntoumi@hotmail.com.
  • Yeboah-Manu D; Department of Bacteriology, Noguchi Memorial Institute for Medical Research, Accra, Ghana. Electronic address: dyeboah-manu@noguchi.ug.edu.gh.
  • Vilaplana C; Experimental Tuberculosis Unit (UTE), Fundació Institut Germans Trias i Pujol (IGTP), Universitat Autònoma de Barcelona (UAB), Badalona, Catalonia, Spain. Electronic address: cvilaplana@gmail.com.
  • Zumla A; Division of Infection and Immunity, University College London and NIHR Biomedical Research Centre, UCL Hospitals NHS Foundation Trust, London, UK. Electronic address: a.zumla@ucl.ac.uk.
  • Maeurer M; ImmunoSurgery Unit, Champalimaud Centre for the Unknown, Lisbon, Portugal; Department of Oncology and Haematology, Krankenhaus Nordwest, Frankfurt am Main, Germany. Electronic address: markus.maeurer@fundacaochampalimaud.pt.
Int J Infect Dis ; 80S: S62-S67, 2019 Mar.
Article em En | MEDLINE | ID: mdl-30685590

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tuberculose Resistente a Múltiplos Medicamentos / Medicina de Precisão / Mycobacterium tuberculosis / Antituberculosos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tuberculose Resistente a Múltiplos Medicamentos / Medicina de Precisão / Mycobacterium tuberculosis / Antituberculosos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article